My Fund Comparison
Initilizing list...
|
Tekla Healthcare Opportunities Fund as of
11/18/2019
| NYSE /
THQ |
Asset Class:
Sector Equity Funds
|
1 YR Lipper Avg:
10.46% |
| Growth of $10K |
|
| Avg Annual Total Return % |
| |
10 YR |
5 YR |
1 YR |
YTD |
| Market Return |
-- |
6.92% |
9.24% |
15.65% |
| Lipper Pct. Rank |
-- |
36 |
54 |
87 |
|
| NAV Return |
-- |
7.01% |
7.78% |
16.13% |
| Lipper Pct. Rank |
-- |
31 |
60 |
55 |
| Premium/Discount History |
|
| Premium/Discount |
| 10 YR Avg |
5 YR Avg |
YTD Avg |
|
-- |
-8.944% |
7.500% |
|
| NAV |
$20.12 |
Market Price |
$18.20 |
| Net Change |
-$0.04 |
Market Change |
-$0.05 |
| Premium/Discount |
-9.54% |
| 1 YR NAV Return |
7.781% |
| 1 YR NAV Rank |
60 |
| 12-Mo Yield as of
10/31/2019 |
Yield
Def |
| Income Only Yield |
0.69% |
| Distribution Yield (Market) |
7.50% |
| Most Recent Income Dividend |
$0.113 |
| Ex-Div Date |
10/17/2019 |
| Most Recent Cap Gain Dividend |
$0.113 |
| Ex-Div Date |
9/17/2014 |
| Dividend Frequency |
Monthly |
| YTD Dividends |
$1.125 |
| YTD Capital Gains |
-- |
| Inception Date |
7/31/2014 |
| Fund Advisor |
Tekla Capital Management LLC |
| Manager & Tenure |
Team Managed |
| Phone |
800-426-5523 |
| Website |
www.teklacap.com |
| Total Net Assets (mil)
as of
10/31/2019 |
$819.5 |
| % Leveraged Assets
as of
9/30/2018 |
21.53% |
| Portfolio Turnover |
40.00% |
| Mgmt Fees |
1.274% |
| Expense Ratio |
2.210% |
| Fund Objective |
| The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Trust expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity securities, debt securities, and pooled investment vehicles. |
|
| Top Holdings
(as of 6/30/2019) |
|
Johnson & Johnson ORD |
9.51% |
|
Pfizer Inc ORD |
6.73% |
|
Merck & Co Inc ORD |
6.13% |
|
UnitedHealth Group Inc ORD |
6.07% |
|
Abbott Laboratories ORD |
3.56% |
|
Medtronic PLC ORD |
3.28% |
|
Thermo Fisher Scientific Inc ORD |
3.28% |
|
Amgen Inc ORD |
3.21% |
|
Gilead Sciences Inc ORD |
2.66% |
|
Abbvie Inc ORD |
2.59% |
|
| Top Sectors
(as of 6/30/2019) |
|
Health Care |
87.31% |
|
Financials |
5.81% |
|
Consumer Services |
4.27% |
|
Non Classified Equity |
2.00% |
|
Industrials |
1.95% |
|
|
Resources
Aberdeen Closed-End TV
Asset TV — CEF Channel
CEF Connect
Cohen & Steers CEFs Knowledge Center
Harvest — CEFA Channel
Legg Mason CEFs
Seeking Alpha — CEFA Channel
|
|
Powered by a SySys® data & content management system.
© Thomson Reuters 2019. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|